Zoll Lifevest Wearable Cardioverter Defibrillator denials: what the review data shows
Independent reviewers have decided 13 published cases where an insurer denied Zoll Lifevest Wearable Cardioverter Defibrillator — and they overturned the insurer 69.2% of the time. A denial for Zoll Lifevest Wearable Cardioverter Defibrillator is a starting position, not a final answer.
These are outcomes from California’s external review program — an independent physician panel that binds the insurer. Every state has an equivalent process, and internal appeals succeed even more often. Cite the outcome record for Zoll Lifevest Wearable Cardioverter Defibrillatorwhen you appeal: reviewers routinely find that denials like yours didn’t hold up.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY